87 related articles for article (PubMed ID: 2783703)
1. Fluoxetine versus imipramine.
Loeb C; Albano C; Gandolfo C
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():75-9. PubMed ID: 2783703
[No Abstract] [Full Text] [Related]
2. Characteristics of responders to fluoxetine.
Reimherr FW; Wood DR; Byerley B; Brainard J; Grosser BI
Psychopharmacol Bull; 1984; 20(1):70-2. PubMed ID: 6371874
[No Abstract] [Full Text] [Related]
3. Fluoxetine in depressed patients: a comparison with imipramine.
Bremner JD
J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
[TBL] [Abstract][Full Text] [Related]
4. A double-blind study of fluoxetine and imipramine in major depression.
Bressa GM; Brugnoli R; Pancheri P
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():69-73. PubMed ID: 2783701
[TBL] [Abstract][Full Text] [Related]
5. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Cohn JB; Wilcox C
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
Byerley WF; Reimherr FW; Wood DR; Grosser BI
J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder.
Taneri Z; Köhler R
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():57-61. PubMed ID: 2783700
[No Abstract] [Full Text] [Related]
8. Fluoxetine versus clomipramine in major depressive disorders.
Ropert R
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():89-95. PubMed ID: 2644343
[No Abstract] [Full Text] [Related]
9. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
Stark P; Hardison CD
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness.
Lenox RH; Shipley JE; Peyser JM; Williams JM; Weaver LA
Psychopharmacol Bull; 1984; 20(1):79-82. PubMed ID: 6144136
[No Abstract] [Full Text] [Related]
11. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.
Feighner JP; Boyer WF; Merideth CH; Hendrickson GG
Int Clin Psychopharmacol; 1989 Apr; 4(2):127-34. PubMed ID: 2663975
[TBL] [Abstract][Full Text] [Related]
12. A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders.
Tamminen TT; Lehtinen VV
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():51-6. PubMed ID: 2783699
[No Abstract] [Full Text] [Related]
13. A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression.
Stratta P; Bolino F; Cupillari M; Casacchia M
Int Clin Psychopharmacol; 1991; 6(3):193-6. PubMed ID: 1806625
[No Abstract] [Full Text] [Related]
14. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.
Nielsen BM; Behnke K; Arup P; Christiansen PE; Geisler A; Ipsen E; Maach-Møller B; Ohrberg SC
Acta Psychiatr Scand; 1993 Apr; 87(4):269-72. PubMed ID: 8488748
[TBL] [Abstract][Full Text] [Related]
15. Imipramine for treatment of chronic depression.
Kocsis JH; Frances A; Mann JJ; Sweeney J; Voss C; Mason B; Brown RP
Psychopharmacol Bull; 1985; 21(3):698-700. PubMed ID: 3898184
[No Abstract] [Full Text] [Related]
16. Maintenance imipramine treatment following postpsychotic depression.
Siris SG; Cutler J; Owen K; Lang MP
Psychopharmacol Bull; 1989; 25(1):85-8. PubMed ID: 2672073
[No Abstract] [Full Text] [Related]
17. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
[No Abstract] [Full Text] [Related]
18. Low-dose fluoxetine therapy for depression.
Wernicke JF; Dunlop SR; Dornseif BE; Bosomworth JC; Humbert M
Psychopharmacol Bull; 1988; 24(1):183-8. PubMed ID: 3290940
[No Abstract] [Full Text] [Related]
19. Effect of dose escalation after low-dose fluoxetine therapy.
Dornseif BE; Dunlop SR; Potvin JH; Wernicke JF
Psychopharmacol Bull; 1989; 25(1):71-9. PubMed ID: 2672072
[No Abstract] [Full Text] [Related]
20. Cortisol differentially predicts response to imipramine and alprazolam.
Ettigi PE; Goldberg SC; Schulz PM; Hamer RM; Blackard WG
Psychopharmacol Bull; 1988; 24(1):206-9. PubMed ID: 3290942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
